RFI Ingredients announced a partnership with Aventus Innovations Inc. to support the commercialization of NutraJIT, Aventus’ sustained-release delivery platform, in the U.S.

RFI will serve as the distribution partner, providing formulators and brands with access to the proprietary delivery technology designed to safeguard active ingredients from gastric degradation and deliver them through sustained release to optimize their functional efficiency.

Delivery systems help to differentiate products by enhancing effectiveness. NutraJIT utilizes a patented pH triggered coacervation process to enable controlled, sustained release of active ingredients over time, maintaining consistent nutrient levels while improving tolerability and user experience.

“This collaboration is built on a shared commitment to deliver value,” said William Brochu, chief operating officer at Aventus Innovations. “By combining Aventus’ delivery technology with RFI’s proximity to U.S. formulators and brands, we can support innovation in a way that is practical and market-driven.”

The partnership expands RFI’s portfolio beyond ingredients to include advanced delivery technologies. RFI is equipped to incorporate NutraJIT across a wide range of applications.

“This partnership aligns perfectly with our mission to support innovation at every level of product development,” said Jeff Wuagneux, CEO of RFI. “Aventus brings a highly practical, science-backed delivery platform, and together, we can help brands create more effective products that meet evolving consumer expectations.”

NutraJIT is compatible with vitamins, minerals, botanicals, amino acids, and probiotics. U.S. customers have immediate access to the class of delivery solutions.